SCHEMBL1089306

SCHEMBL1089306

O=C(COc1ccccc1)N1CCC(N2CCCCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.55
CXCR4 P61073 1/20 0.51
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
TP53 P04637 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CPT2 P23786 3/20 0.45
CPT1A P50416 3/20 0.45
POLB P06746 1/20 0.45
LMNA P02545 1/20 0.44
CPT1B Q92523 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HRH4 Q9H3N8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090390 0.98 ACHE (0.55) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1089817 0.96 CXCR4 (0.54) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1090693 0.92 ACHE (0.49) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1089928 0.92 CXCR4 (0.50) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1090708 0.91 CXCR4 (0.51) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1090456 0.90 SMN1; SMN2 (0.49) ACHECXCR4KDM4EALDH1A1TDP1
SCHEMBL1089881 0.90 CXCR4 (0.54) ACHECXCR4HRH4
SCHEMBL1090876 0.89 HRH4 (0.48) ACHECXCR4SMN1; SMN2CYP2D6CYP2C19
SCHEMBL1090824 0.88 CXCR4 (0.58) ACHECXCR4KDM4EALDH1A1HRH4
SCHEMBL1089338 0.88 CXCR4 (0.54) ACHECXCR4HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ACHE 4384/4885CXCR4 1/4885KDM4E 2001/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ACHE 4384/4885CXCR4 1/4885KDM4E 2001/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ACHE 4384/4885CXCR4 1/4885KDM4E 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.